Clinical Roundup Nivolumab + epigenetic drug induce immune response in some resistant pancreatic cancers November 22, 2024Vol.50 No.44
Clinical Roundup Remote telemedicine tool found highly accurate in diagnosing melanoma November 22, 2024Vol.50 No.44
Clinical Roundup UVA Health tests focused ultrasound to increase immune response in melanoma November 22, 2024Vol.50 No.44
Clinical Roundup Model created by Cedars-Sinai investigators could speed patient selection for clinical trials November 22, 2024Vol.50 No.44
Clinical Roundup VHIO’s novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors November 22, 2024Vol.50 No.44
Clinical Roundup Hemokine modulatory regimen shows promise for TNBC in phase I study November 22, 2024Vol.50 No.44
Clinical Roundup Fralin Biomedical Research Institute spinoff company focuses on peptide drugs targeting cancer stem cells November 22, 2024Vol.50 No.44
Clinical Roundup Data from Gardasil 9 studies reinforce importance of gender-neutral HPV vaccination in adults November 15, 2024Vol.50 No.43
Clinical Roundup Only half of young patients with cancer report a discussion on fertility preservation November 15, 2024Vol.50 No.43
Clinical Roundup Combination immunotherapy + chemo is safe and effective for advanced small cell cancers in bladder and prostate November 15, 2024Vol.50 No.43
